Korean J Gastroenterol.  2019 Jul;74(1):11-16. 10.4166/kjg.2019.74.1.11.

Diagnosis and Management of Barrett's Esophagus, Dysplasia and Early Esophageal Adenocarcinoma: Focusing on American and European Guidelines

• Yoo AY
• Joo MK

• KMID: 2453254
• DOI: http://doi.org/10.4166/kjg.2019.74.1.11

Abstract

Barrett's esophagus (BE) is one of the most prominent diseases in Western countries because of its potential to progress to dysplasia or adenocarcinoma. Recently, the American College of Gastroenterology (ACG), American Gastroenterology Association (AGA), and European Society of Gastrointestinal Endoscopy (ESGE) developed clinical guidelines for the diagnosis and management of BE. All three guidelines commonly stressed the necessity of the endoscopic eradication of confirmed, nonnodular low grade dysplasia or high grade dysplasia, as well as the endoscopic elimination of the remaining BE after an endoscopic resection of visible mucosal abnormalities. An endoscopic resection is also considered for the optimal management of esophageal adenocarcinoma confined to the mucosa (T1a), and even in selective cases of submucosal invasion (T1b). As endoscopic therapy becomes the mainstay for the treatment of BE and its complications, the eligibility of pathologic or endoscopic experts and the BE expert center are being set and strengthened. This paper introduces the statements of the ACG, AGA and ESGE guidelines and compares the similarities and differences between them.

Keyword

Barrett esophagus; Esophageal neoplasms; Adenocarcinoma

MeSH Terms

Adenocarcinoma*
Barrett Esophagus*
Diagnosis*
Endoscopy, Gastrointestinal
Esophageal Neoplasms
Gastroenterology
Mucous Membrane

Reference

1. Sharma P, McQuaid K, Dent J, et al. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago workshop. Gastroenterology. 2004; 127:310–330.

2. Falk GW. Barrett's esophagus. Gastroenterology. 2002; 122:1569–1591.

3. Kim JY, Kim YS, Jung MK, et al. Prevalence of Barrett's esophagus in Korea. J Gastroenterol Hepatol. 2005; 20:633–636.

4. Park JJ, Kim JW, Kim HJ, et al. The prevalence of and risk factors for Barrett's esophagus in a Korean population: a nationwide multicenter prospective study. J Clin Gastroenterol. 2009; 43:907–914.

5. Hwang JK, Kim J, Hong SG, et al. A prospective multicenter study on the prevalence and symptoms of erosive reflux esophagitis in secondary and tertiary hospitals in Korea. Korean J Gastroenterol. 2009; 53:283–291.

6. Kim N, Lee SW, Cho SI, et al. The prevalence of and risk factors for erosive oesophagitis and non-erosive reflux disease: a nation-wide multicentre prospective study in Korea. Aliment Pharmacol Ther. 2008; 27:173–185.

7. Shaheen NJ, Falk GW, Iyer PG, Gerson LB, American College. ACG clinical guideline: diagnosis and management of Barrett's esophagus. Am J Gastroenterol. 2016; 111:30–50.

8. Wani S, Rubenstein JH, Vieth M, Bergman J. Diagnosis and management of low-grade dysplasia in Barrett's esophagus: expert review from the clinical practice updates committee of the American Gastroenterological Association. Gastroenterology. 2016; 151:822–835.

9. Fitzgerald RC, di Pietro M, Ragunath K, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut. 2014; 63:7–42.

10. Koop H, Fuchs KH, Labenz J, et al. S2k guideline: gastroesophageal reflux disease guided by the German Society of Gastroenterology: AWMF register no. 021-013. Z Gastroenterol. 2014; 52:1299–1346.

11. Weusten B, Bisschops R, Coron E, et al. Endoscopic management of Barrett's esophagus: European Society of Gastrointestinal Endoscopy (ESGE) position statement. Endoscopy. 2017; 49:191–198.

12. Barrett-oesofagus. [Internet]. Haarlem: Nederlandse Vereniging van Maag-Darm-Leverartsen;c2018. cited 2019 Jun 6. Available from: https://www.mdl.nl/sites/www.mdl.nl/files/richlijnen/Richtlijnen%20Barrett%20oesofagus%20-%20jan%202018%20-%20tbv%20website.pdf.

13. Weusten B, Bisschops R, Coron E, et al. Endoscopic management of Barrett's esophagus: European Society of Gastrointestinal Endoscopy (ESGE) position statement. Endoscopy. 2017; 49:191–198.

14. Visrodia K, Singh S, Krishnamoorthi R, et al. Magnitude of missed esophageal adenocarcinoma after Barrett's esophagus diagnosis: a systematic review and meta-analysis. Gastroenterology. 2016; 150:599–607.e7. quiz e14-e15.